Abstract
Isoxicam is a potent, orally active, nonsteroidal anti-inflammatory drug with prolonged activity in experimentally induced inflammation in rats. Isoxicam is less ulcerogenic, acutely less toxic and, therefore, appears to have a therapeutic ratio superior to other standard agents to which it was compared.
Similar content being viewed by others
References
C. A. Winter, Ann. Rev. Pharmac.6, 157 (1966).
T. Y. Shen, Angew. Chem. Int.11, 460 (1972).
J. G. Lombardino andE. H. Wiseman., J. Med. Chem.14, 973 (1971).
E. H. Wiseman andJosephine Chiani, Biochem. Pharmac.21, 2323 (1972).
H. Zinnes, N. A. Lindo, J. C. Sircar, M. L. Schwartz, J. Shavel, Jr., andG. DiPasquale, J. Med. Pharm. Chem.16, 44 (1973).
G. DiPasquale C. L. Rassaert, R. S. Richter andL. V. Tripp, Arch. Int. Pharmacodyn. Ther.203, 92 (1973).
C. A. Winter, E. A. Risley andG. W. Nuss, J. Pharmac. exp. Ther.141, 369 (1963).
G. DiPasquale andLenore Tripp, Steroids16, 693 (1970).
Ira Ringler, in:Methods in Hormone Research III (Academic Press, New York 1964).
O. J. Lorenzetti, Pharmac.9, 242 (1970).
J. Wax, C. V. Winder, D. K. Tessman andM. D. Stephens, J. Pharmac. exp. Ther.192, 172 (1975).
D. A. Brodie, P. G. Cook, B. J. Bauer andG. E. Dagle, Toxic. appl. Pharmac.17, 615 (1970).
G. Volterra, N. Pisanti andA. Meli, Proc. Soc. exp. Biol. Med.146, 146 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DiPasquale, G., Rassaert, C., Richter, R. et al. The anti-inflammatory properties of isoxicam (4-hydroxy-2-methyl-N-[5-Methyl-3-isoxolyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide]). Agents and Actions 5, 256–263 (1975). https://doi.org/10.1007/BF02026440
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02026440